Triple Negative Breast Cancer Pipeline Insight A growing number of innovative therapies for triple-negative breast cancer (TNBC) – including TECENTRIQ (Hoffmann-La Roche), IPI-549 (Infinity Pharmaceuticals), Leronlimab (CytoDyn), MDNA11 (Medicenna Therapeutics),
Colorectal Cancer Competitive Landscape Leading companies active in the colorectal cancer space include Nektar Therapeutics, ALX Oncology Inc., Processa Pharmaceuticals, Guojian Pharmaceutical, Gritstone Bio, Daiichi Sankyo, Novartis Pharmaceuticals, Shanghai Henlius
Muscle Invasive Bladder Cancer Competitive Landscape Leading companies operating in the Muscle Invasive Bladder Cancer (MIBC) space include Merck Sharp & Dohme LLC, Aura Biosciences, Janssen Research & Development, LLC,
Severe Asthma Clinical Trial Prominent companies actively shaping the severe asthma treatment space include Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology, AB Science, GlaxoSmithKline, Oneness Biotech, Biosion, Lanier Biotherapeutics,
Obesity Clinical Trial Major companies active in the obesity space include Pfizer, Biolingus, Regor Pharmaceuticals, Zealand Pharma, Sirnaomics, Innovent Biologics, PegBio, NodThera Limited, Sciwind Biosciences, Boehringer Ingelheim, Clearmind Medicine, Sparrow
DelveInsight’s, “B-cell Lymphoma Pipeline Insight, 2025” report provides comprehensive insights about 295+ companies and 300+ pipeline drugs in B-cell Lymphoma pipeline landscape. It covers the B-Cell Lymphoma pipeline drug profiles,
DelveInsight’s, “EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in EGFR Non-Small Cell Lung Cancer (EGFR
DelveInsight’s “Glioblastoma Pipeline Insight, 2025” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in Glioblastoma pipeline landscape. It covers the Glioblastoma pipeline drug profiles, including clinical and
DelveInsight’s “Gastric Cancer Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in the Gastric Cancer pipeline landscape. It covers the Gastric Cancer pipeline drug
DelveInsight’s, “Systemic Lupus Erythematosus Pipeline Insights 2025” report provides comprehensive insights about 120+ companies and 140+ pipeline drugs in Systemic Lupus Erythematosus pipeline landscape. It covers the Systemic Lupus Erythematosus
DelveInsight’s “Glioma Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the glioma pipeline landscape. It covers the Glioma pipeline drug profiles, including clinical
DelveInsight’s, “Hemophagocytic Lymphohistiocytosis Pipeline Insights 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Hemophagocytic Lymphohistiocytosis pipeline landscape. It covers the Hemophagocytic Lymphohistiocytosis pipeline drug profiles,
DelveInsight’s, “Mantle Cell Lymphoma Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Mantle Cell Lymphoma pipeline landscape. It covers the Mantle Cell Lymphoma
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myositis pipeline constitutes 18+ key companies continuously working towards developing 20+ Myositis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism
The Key Ichthyosis Companies in the market include – Timber Pharmaceuticals, Krystal Biotech, GSK, Timber Pharmcecuticals, Janssen Scientific, Patagonia Pharma, Timber Pharmcuticals, Crown Laboratories, Inc, and others. DelveInsight’s “Ichthyosis
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Facioscapulohumeral Muscular Dystrophy pipeline constitutes 10+ key companies continuously working towards developing 12+ Facioscapulohumeral Muscular Dystrophy treatment therapies, analysis of
The Key Idiopathic Pulmonary Fibrosis Companies in the market inlcude – Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma, Tvardi Therapeutics, Pliant Therapeutics, Inc., GlaxoSmithKline, Amgen, Bristol-Myers Squibb, Endeavor Biomedicines, Syndax Pharmaceuticals,
HANGZHOU, China – The preliminary review round of the 20th Hardware Innovation Design Awards recently concluded at the China · Yongkang Science and Innovation Hub in Hangzhou. The prestigious competition attracted
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, NK Cell Therapy pipeline constitutes 140+ key companies continuously working towards developing 160+ Nk Cell Therapy treatment therapies, analysis of
This Game Day, Decode Your Body’s “Score”: Stress, Excitement, and Recovery, All at Your Fingertips. Before the first whistle blows at the Game Day, let’s talk about momentum. Dreame is
